Skip to Content

Allegra-D 24 Hour Approval History

FDA Approved: Yes (First approved October 19, 2004)
Brand name: Allegra-D 24 Hour
Generic name: fexofenadine and pseudoephedrine
Company: Sanofi Aventis US
Treatment for: Allergic Rhinitis, Nasal Congestion

Allegra-D 24 Hour (fexofenadine and pseudoephedrine) is a once daily prescription antihistamine and decongestant formulation approved for the treatment of seasonal allergy symptoms with nasal congestion in adults and children 12 years of age and older.

Development History and FDA Approval Process for Allegra-D 24 Hour

DateArticle
Oct 19, 2004Approval Allegra-D 24 Hour Aventis Pharmaceuticals Inc. - Treatment for Seasonal Allergy Symptoms with Nasal Congestion
Jan 15, 2004New Drug Application Submitted for Once-Daily Allegra-D (fexofenadine HCl 180 mg/pseudoephedrine HCl 240 mg) Formulation Using aaiPharma's Development Expertise

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide